However, further investigation is required to determine whether TGF-β modulation contributes to these effects and, indeed, whether other pathogenic features of CF associated with increased TGF-β signalling such as neutrophil chemotaxis can be modulated by furin inhibition. This evidence concerns the gene FURIN and cystic fibrosis.